AHR and chronic kidney disease: Recent evidence has shown that the uremic toxin IS‐activated AhR promotes thrombosis and endovascular injury by inhibiting tissue factor ubiquitination and degradation.[28] However, understanding the pathological function of AhR in intrinsic renal cells in CKD is quite limited.